Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €26.27 EUR
Change Today +0.23 / 0.88%
Volume 3.0M
As of 12:35 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

koninklijke philips nv (PHIA) Snapshot

Open
€26.28
Previous Close
€26.04
Day High
€26.44
Day Low
€26.07
52 Week High
03/19/15 - €27.68
52 Week Low
10/23/14 - €20.69
Market Cap
24.6B
Average Volume 10 Days
3.7M
EPS TTM
€0.46
Shares Outstanding
934.8M
EX-Date
05/11/15
P/E TM
57.3x
Dividend
€0.80
Dividend Yield
3.05%
Current Stock Chart for KONINKLIJKE PHILIPS NV (PHIA)

koninklijke philips nv (PHIA) Related Bloomberg News

View More Bloomberg News

koninklijke philips nv (PHIA) Details

Koninklijke Philips N.V. engages in healthcare, consumer lifestyle, and lighting businesses worldwide. It provides various integrated clinical solutions, including radiation oncology and portfolio management; computed tomography, magnetic resonance imaging, and molecular imaging products; digital X-ray and mammography products; interventional X-ray products in cardiology, radiology, surgery, and other areas; and ultrasound products. The company also offers enterprise patient monitoring solutions for clinical information at the patient’s bedside; patient analytics, patient monitoring, and clinical decision support systems; mother and child care products; therapeutic care products; imaging informatics for radiology and cardiology; picture archiving and communication systems and integrated electronic medical record systems; professional services; clinical support and performance, education, value-added services, installation, and remote proactive monitoring services; and care coordination, home monitoring, and care solutions. In addition, it provides mother and childcare, oral healthcare, pain management, male grooming, and beauty products; and kitchen appliances, coffee, garment care, floor care, and air purification products. Further, the company is involved in the development, manufacture, and application of various lighting products and services, including light sources and electronics, such as LED, eco-halogen, fluorescent, discharge, and incandescent light sources, as well as electronic and electromagnetic gears, modules, and drivers; functional, decorative, lifestyle, and scene-setting luminaires; and controls and luminaires for city beautification, road and sports lighting, office lighting, shop/hospitality lighting, and industry lighting. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is based in Amsterdam, the Netherlands.

105,365 Employees
Last Reported Date: 02/24/15
Founded in 1891

koninklijke philips nv (PHIA) Top Compensated Officers

Chairman of the Board of Management, Chief Ex...
Total Annual Compensation: €1.5M
Chief Financial Officer, Executive Vice-Presi...
Total Annual Compensation: €869.1K
Executive Vice-President, Member of Board of ...
Total Annual Compensation: €901.9K
Compensation as of Fiscal Year 2014.

koninklijke philips nv (PHIA) Key Developments

Philips and Leiden University Medical Center Extend Collaboration with New Research Agreement on Healthy Aging and Personal Health

Royal Philips and Leiden University Medical Center (LUMC) announced a new research collaboration aimed at improving preventative care and chronic care through wearable technologies. The organizations intend to attain new data-driven insights into the relationship between lifestyle and health in elderly people. This will support the development of personalized coaching solutions using wearable sensors to help people to age more healthy and reduce the impact of illness and chronic conditions. As people live longer and lifestyles change, more people are confronted with chronic disease. In addition to having a major impact on peoples quality of life, this puts increased pressure on healthcare systems. New wearable sensor technologies are rapidly becoming available and could play an important role in healthy lifestyles and treatment compliance. The current challenge is to turn the data these new devices offer into clinically relevant information. This will help build scientifically proven and clinically validated solutions to improve the outcomes of lifestyle intervention programs and medical treatments.

Royal Philips and Leiden University Medical Center Announces New Research Collaboration

Royal Philips and Leiden University Medical Center (LUMC) announced a new research collaboration aimed at improving preventative care and chronic care through wearable technologies. The organizations intend to attain new data-driven insights into the relationship between lifestyle and health in elderly people. This will support the development of personalized coaching solutions using wearable sensors to help people to age more healthy and reduce the impact of illness and chronic conditions. As people live longer and lifestyles change, more people are confronted with chronic disease. In addition to having a major impact on peoples quality of life, this puts increased pressure on healthcare systems. New wearable sensor technologies are rapidly becoming available and could play an important role in healthy lifestyles and treatment compliance. The current challenge is to turn the data these new devices offer into clinically relevant information. This will help build scientifically proven and clinically validated solutions to improve the outcomes of lifestyle intervention programs and medical treatments.

Royal Philips & Janssen Pharmaceutica Collaborate to Develop Handheld Blood Test

Royal Philips announced it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V. to develop a new handheld blood test to support the care of patients with neuropsychiatric disorders. The blood test will be based on Philips' Minicare I-20 system for immunoassays. Janssen will be responsible for the clinical studies to validate the test, as well as the commercialization of the final product.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHIA:NA €26.27 EUR +0.23

PHIA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bridgestone Corp ¥4,777 JPY +31.00
Eaton Corp PLC $66.70 USD +0.03
FUJIFILM Holdings Corp ¥4,204 JPY -9.50
Linde AG €187.78 EUR -0.348
Mitsubishi Electric Corp ¥1,426 JPY -4.00
View Industry Companies
 

Industry Analysis

PHIA

Industry Average

Valuation PHIA Industry Range
Price/Earnings 97.0x
Price/Sales 1.0x
Price/Book 2.0x
Price/Cash Flow 53.3x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KONINKLIJKE PHILIPS NV, please visit www.philips.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.